Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease

Trends in Molecular Medicine

Volumn 12, Issue 12, 2006, Pages 555-558

  Videla, Luis A ^a   Rodrigo, Ramón ^a   Araya, Julia ^a   Poniachik, Jaime ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CYTOCHROME P450 2E1; GLUTATHIONE; LONG CHAIN FATTY ACID; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNCOMPLICATED TRIACYLGLYCEROL;

CHRONIC LIVER DISEASE; DISEASE COURSE; DISEASE EXACERBATION; DNA DAMAGE; FATTY LIVER; HUMAN; INSULIN RESISTANCE; LIPID PEROXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER DISEASE; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PREVALENCE; PROTEIN EXPRESSION; SHORT SURVEY; TREATMENT PLANNING;

CYTOKINES; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, UNSATURATED; FATTY LIVER; HUMANS; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; LIVER; MODELS, BIOLOGICAL; OBESITY; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 33751193496     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2006.10.001     Document Type: Short Survey

References (19)

1. Angulo P. NAFLD, obesity, and bariatric surgery. Gastroenterology 130 (2006) 1848-1852
2. Houstis N., et al. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440 (2006) 944-948
3. Araya J., et al. Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in non-alcoholic fatty liver disease patients. Clin. Sci. 106 (2004) 635-643
4. Aronis A., et al. Mechanism underlying oxidative stress-mediated lipotoxicity: exposure of J774.2 macrophages to triacylglycerols facilitates mitochondrial reactive oxygen species production and cellular necrosis. Free Radic. Biol. Med. 38 (2005) 1221-1230
5. Videla L.A., et al. Oxidative stress and depletion of hepatic polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease. Free Radic. Biol. Med. 37 (2004) 1499-1507
6. Videla L.A., et al. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin. Sci. 106 (2004) 261-268
7. Sies H., et al. Nutritional, dietary and postprandial oxidative stress. J. Nutr. 135 (2005) 969-972
8. Lieber C.S. CYP2E1: from ASH to NASH. Hepatol. Res. 28 (2004) 1-11
9. Woodcroft K.J., et al. Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression. Hepatology 35 (2002) 263-273
10. Orellana M., et al. Relationship between in vivo chlorzoxazone hydroxylation, hepatic cytochrome P450 2E1 content, and liver injury in obese non-alcoholic fatty liver disease patients. Hepatol. Res. 34 (2006) 57-63
11. Evans J.L., et al. The molecular basis for oxidative stress-induced insulin resistance. Antioxid. Redox Signal. 7 (2005) 1040-1052
12. Petersen K.F., et al. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54 (2005) 603-608
13. Lombardo Y.B., and Chico A.G. Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. J. Nutr. Biochem. 17 (2006) 1-13
14. Poniachik J., et al. Increased production of IL-1α and TNF-α in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease. Cytokine 33 (2006) 252-257
15. Tsukamoto H. Redox regulation of cytokine expression in Kupffer cells. Antioxid. Redox Signal. 4 (2002) 741-748
16. 2-terminal kinase pathways in inflammation and origin of obesity and diabetes. Diabetes 54 (2005) S73-S78
17. Mathurin P., et al. The evolution of severe steatosis after bariatric surgery is related to insulin resistance. Gastroenterology 130 (2006) 1617-1624
18. Klein S., et al. Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology 130 (2006) 1564-1572
19. Lieber C.S. The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metab. Rev. 36 (2004) 511-529